Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Renal Cell 86Kidney Neoplasms 25Neoplasms 24Breast Neoplasms 18Gastrointestinal Stromal Tumors 17Neoplasm Metastasis 15Carcinoma, Non-Small-Cell Lung 15Prostatic Neoplasms 8Urinary Bladder Neoplasms 7Brain Neoplasms 7Pancreatic Neoplasms 6Lung Neoplasms 6Colorectal Neoplasms 6Thyroid Neoplasms 5Stomach Neoplasms 5Solid Tumors 5Small Cell Lung Carcinoma 5Ovarian Neoplasms 5Neuroendocrine Tumors 5Melanoma 5Glioblastoma 5Carcinoma 5Sarcoma 4Liver Neoplasms 4Esophageal Neoplasms 4Clear-cell metastatic renal cell carcinoma 4Carcinoma, Hepatocellular 4Astrocytoma 4Adenoma, Islet Cell 4Thyroid Cancer, Papillary 3

Interventions

ribociclib 1napabucasin 1bosutinib 1amrubicin 1Sunitinib 1Radiosurgery 1Quality of Life 1Pemetrexed 1Patient Reported Outcome Measures 1Paclitaxel 1Nivolumab 1Molecular Diagnostic Techniques 1Immunotherapy 1Erlotinib Hydrochloride 1Drug Therapy 1Cisplatin 1Blood Specimen Collection 1Biological Therapy 1Bevacizumab 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Thymus Neoplasms × Sunitinib × Clear all
NCT01621568 2024-09-24

Sunitinib for Advanced Thymus Cancer Following Earlier Treatment

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
56 enrolled 15 charts
Thoracic

Thymoma, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡